Book contents
- Practise Psychiatry
- Practise Psychiatry
- Copyright page
- Contents
- Acknowledgements
- Part 1: Vignettes
- Case 1: Schizophrenia
- Case 2: Delusional Disorder
- Case 3: Major Depressive Disorder
- Case 4: Dysthymic Disorder and Premenstrual Dysphoric Disorder
- Case 5: Grief
- Case 6: Bipolar Disorder
- Case 7: Generalised Anxiety Disorder
- Case 8: Panic Disorder and Agoraphobia
- Case 9: Social Anxiety Disorder
- Case 10: Separation Anxiety and Selective Mutism
- Case 11: Obsessive–Compulsive Disorder
- Case 12: Body Dysmorphic Disorder
- Case 13: Trichotillomania and Excoriation Disorder
- Case 14: Hoarding Disorder
- Case 15: Anorexia Nervosa
- Case 16: Bulimia Nervosa
- Case 17: Pica and Rumination Disorder
- Case 18: Acute Stress Disorder, Post-Traumatic Stress Disorder and Adjustment Disorder
- Case 19: Illness Anxiety Disorder and Somatic Symptom Disorder
- Case 20: Conversion Disorder and Factitious Disorder
- Case 21: Delirium and Neurocognitive Disorders
- Case 22: Mental Capacity Assessment
- Case 23: Attention Deficit Hyperactivity Disorder
- Case 24: Autism Spectrum Disorder and Intellectual Developmental Disorder
- Case 25: Alcohol Use Disorder
- Case 26: Cannabis Use Disorder
- Case 27: Stimulant Use Disorder
- Case 28: Opioid Use Disorder
- Case 29: Hallucinogen Use Disorder
- Case 30: Gambling Disorder
- Case 31: Borderline Personality Disorder
- Case 32: Antisocial Personality Disorder
- Case 33: Schizoid, Schizotypal and Paranoid Personality Disorder
- Case 34: Dependent Personality Disorder
- Case 35: Suicide Risk Assessment
- Case 36: Catatonia and Electroconvulsive Therapy
- Case 37: Neuroleptic Malignant Syndrome and Serotonin Syndrome
- Case 38: Insomnia Disorder
- Case 39: Narcolepsy Disorder
- Case 40: Breathing-Related Sleep Disorders
- Case 41: Non-Rapid Eye Movement Sleep Arousal Disorder
- Case 42: Rapid Eye Movement Sleep Behaviour Disorder
- Case 43: Dissociative Amnesia and Dissociative Identity Disorder
- Case 44: Voyeuristic, Exhibitionistic, Frotteuristic and Sexual Masochism and Sadism Disorders
- Case 45: Paedophilic Disorder
- Case 46: Transvestic and Fetishistic Disorders
- Case 47: Gender Dysphoria
- Case 48: Pyromania
- Case 49: Kleptomania
- Case 50: Child and Adolescent Mental Health Services
- Case 51: Old Age Psychiatry
- Case 52: Pregnancy and Breastfeeding
- Case 53: Hepatic Impairment
- Case 54: Renal Impairment
- Case 55: Forensic Psychiatry
- Part II: Topical MCQs
- Index
- References
Case 23: - Attention Deficit Hyperactivity Disorder
from Part 1: - Vignettes
Published online by Cambridge University Press: 04 September 2025
Book contents
- Practise Psychiatry
- Practise Psychiatry
- Copyright page
- Contents
- Acknowledgements
- Part 1: Vignettes
- Case 1: Schizophrenia
- Case 2: Delusional Disorder
- Case 3: Major Depressive Disorder
- Case 4: Dysthymic Disorder and Premenstrual Dysphoric Disorder
- Case 5: Grief
- Case 6: Bipolar Disorder
- Case 7: Generalised Anxiety Disorder
- Case 8: Panic Disorder and Agoraphobia
- Case 9: Social Anxiety Disorder
- Case 10: Separation Anxiety and Selective Mutism
- Case 11: Obsessive–Compulsive Disorder
- Case 12: Body Dysmorphic Disorder
- Case 13: Trichotillomania and Excoriation Disorder
- Case 14: Hoarding Disorder
- Case 15: Anorexia Nervosa
- Case 16: Bulimia Nervosa
- Case 17: Pica and Rumination Disorder
- Case 18: Acute Stress Disorder, Post-Traumatic Stress Disorder and Adjustment Disorder
- Case 19: Illness Anxiety Disorder and Somatic Symptom Disorder
- Case 20: Conversion Disorder and Factitious Disorder
- Case 21: Delirium and Neurocognitive Disorders
- Case 22: Mental Capacity Assessment
- Case 23: Attention Deficit Hyperactivity Disorder
- Case 24: Autism Spectrum Disorder and Intellectual Developmental Disorder
- Case 25: Alcohol Use Disorder
- Case 26: Cannabis Use Disorder
- Case 27: Stimulant Use Disorder
- Case 28: Opioid Use Disorder
- Case 29: Hallucinogen Use Disorder
- Case 30: Gambling Disorder
- Case 31: Borderline Personality Disorder
- Case 32: Antisocial Personality Disorder
- Case 33: Schizoid, Schizotypal and Paranoid Personality Disorder
- Case 34: Dependent Personality Disorder
- Case 35: Suicide Risk Assessment
- Case 36: Catatonia and Electroconvulsive Therapy
- Case 37: Neuroleptic Malignant Syndrome and Serotonin Syndrome
- Case 38: Insomnia Disorder
- Case 39: Narcolepsy Disorder
- Case 40: Breathing-Related Sleep Disorders
- Case 41: Non-Rapid Eye Movement Sleep Arousal Disorder
- Case 42: Rapid Eye Movement Sleep Behaviour Disorder
- Case 43: Dissociative Amnesia and Dissociative Identity Disorder
- Case 44: Voyeuristic, Exhibitionistic, Frotteuristic and Sexual Masochism and Sadism Disorders
- Case 45: Paedophilic Disorder
- Case 46: Transvestic and Fetishistic Disorders
- Case 47: Gender Dysphoria
- Case 48: Pyromania
- Case 49: Kleptomania
- Case 50: Child and Adolescent Mental Health Services
- Case 51: Old Age Psychiatry
- Case 52: Pregnancy and Breastfeeding
- Case 53: Hepatic Impairment
- Case 54: Renal Impairment
- Case 55: Forensic Psychiatry
- Part II: Topical MCQs
- Index
- References
Summary
Chapter 23 covers the topic of attention deficit hyperactivity disorder(ADHD). Through a case vignette with topical MCQs for consolidation of learning, readers are brought through the diagnosis to management of a patient with attention deficit hyperactivity disorder. Topics covered include symptoms and diagnosis of ADHD, investigations, learning difficulties, management of ADHD, adverse side effects of treatment, management of adverse effects from medications and tic and stereotypy.
Keywords
Information
- Type
- Chapter
- Information
- Practise PsychiatryA Guide Through Vignettes and MCQs, pp. 222 - 233Publisher: Cambridge University PressPrint publication year: 2025
References
World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar
Hollis, C, Hall, CL, Guo, B, James, M, Boadu, J, Groom, MJ, et al. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial. J Child Psychol Psychiatry. 2018 Dec;59(12):1298–308.CrossRefGoogle Scholar
Mueller, F, Brozovich, R, Johnson, CB. Conners’ Rating Scales-Revised (CRS-R). Diagnostique. 1999 Mar;24(1–4):83–97.10.1177/153450849902401-409CrossRefGoogle Scholar
Wolraich, ML. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003 Dec 1;28(8):559–68.CrossRefGoogle Scholar
Kessler, RC, Adler, L, Ames, M, Demler, O, Faraone, S, Hiripi, E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005 Feb;35(2):245–56.CrossRefGoogle Scholar
Schachter, HM, Pham, B, King, J, Langford, S, Moher, D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001 Nov 27;165(11):1475–88.Google ScholarPubMed
Barbaresi, WJ, Katusic, SK, Colligan, RC, Weaver, AL, Leibson, CL, Jacobsen, SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006 Feb;27(1):1–10.CrossRefGoogle ScholarPubMed
Storebø, OJ, Pedersen, N, Ramstad, E, Kielsholm, ML, Nielsen, SS, Krogh, HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069.Google ScholarPubMed
Moran, LV, Ongur, D, Hsu, J, Castro, VM, Perlis, RH, Schneeweiss, S. Psychosis with methylphenidate or amphetamine in patients with ADHD. N Engl J Med. 2019 Mar 21;380(12):1128–38.CrossRefGoogle ScholarPubMed
Samuels, JA, Franco, K, Wan, F, Sorof, JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol. 2006 Jan;21(1):92–5.CrossRefGoogle ScholarPubMed
Fay, TB, Alpert, MA. Cardiovascular effects of drugs used to treat attention-deficit/hyperactivity disorder. Part 2: impact on cardiovascular events and recommendations for evaluation and monitoring. Cardiol Rev. 2019;27(4):173–8.Google ScholarPubMed
Greenhill, LL, Swanson, JM, Hechtman, L, Waxmonsky, J, Arnold, LE, Molina, BSG, et al. Trajectories of growth associated with long-term stimulant medication in the multimodal treatment study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):978–89.CrossRefGoogle ScholarPubMed
Wilens, TE, Faraone, SV, Biederman, J, Gunawardene, S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003 Jan;111(1):179–85.CrossRefGoogle ScholarPubMed
Bangs, ME, Tauscher-Wisniewski, S, Polzer, J, Zhang, S, Acharya, N, Desaiah, D, et al. Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):209–18.10.1097/chi.0b013e31815d88b2CrossRefGoogle ScholarPubMed
Davies, M, Coughtrie, A, Layton, D, Shakir, SAS. Use of atomoxetine and suicidal ideation in children and adolescents: results of an observational cohort study within general practice in England. Eur Psychiatr. 2017 Jan;39:11–6.CrossRefGoogle ScholarPubMed
Sonuga-Barke, EJS, Brandeis, D, Cortese, S, Daley, D, Ferrin, M, Holtmann, M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013 Mar;170(3):275–89.10.1176/appi.ajp.2012.12070991CrossRefGoogle ScholarPubMed
Bloch, MH, Qawasmi, A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991–1000.CrossRefGoogle ScholarPubMed
Barragán, E, Breuer, D, Döpfner, M. Efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Atten Disord. 2017 Mar;21(5):433–41.10.1177/1087054713518239CrossRefGoogle Scholar
Wolraich, ML, Hagan, JF, Allan, C, Chan, E, Davison, D, Earls, M, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019 Oct;144(4):e20192528.10.1542/peds.2019-2528CrossRefGoogle ScholarPubMed
Sampson, HA, Aceves, S, Bock, SA, James, J, Jones, S, Lang, D, et al. Food allergy: a practice parameter update – 2014. J Allergy Clin Immunol. 2014 Nov;134(5):1016–1025.e43.10.1016/j.jaci.2014.05.013CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline [NG87]. NICE; 2018. Available from: www.nice.org.uk/guidance/NG87Google Scholar
Rojas, NL, Chan, E. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder. Ment Retard Dev Disabil Res Rev. 2005;11(2):116–30.Google ScholarPubMed
Nigg, JT, Lewis, K, Edinger, T, Falk, M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):86–97.e8.10.1016/j.jaac.2011.10.015CrossRefGoogle ScholarPubMed
Millichap, JG, Yee, MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics. 2012 Feb;129(2):330–7.10.1542/peds.2011-2199CrossRefGoogle ScholarPubMed
Jankovic, J, Kurlan, R. Tourette syndrome: evolving concepts. Mov Disord. 2011 May;26(6):1149–56.10.1002/mds.23618CrossRefGoogle ScholarPubMed
Accessibility standard: Inaccessible, or known limited accessibility
The PDF of this book is known to have missing or limited accessibility features.
We may be reviewing its accessibility for future improvement, but final compliance is
not yet assured and may be subject to legal exceptions. If you have any questions,
please contact
accessibility@cambridge.org.
Content Navigation
Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Reading Order & Textual Equivalents
Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
Visual Accessibility
Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
Structural and Technical Features
ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.